VP, Global Head of Data Science
Odysseus Data Services Inc.
New York, United States
Asieh Golozar, MD PhD MHS MPH, is a Director of Pharmacoepidemiology at Regeneron Pharmaceuticals, Inc. where she is the Therapeutic Lead for Oncology Pharmacoepidemiology. In this role, she guides the integration of Epidemiology into clinical development and post-marketing activities; in addition, to designing and directing the utilization of cutting edge, effective, and innovative Real-World Evidence strategies in support of drug discovery, clinical development, and life cycle management.
Dr. Golozar received her Doctoral degree in Epidemiology and a Master of Health Sciences in Biostatistics from Johns Hopkins University (JHU), School of Public Health. A postdoctoral research fellowship from the National Cancer Institute, Division of Cancer Epidemiology and Genetics supported this work. Prior to that, she trained as a medical doctor at the Tehran University of Medical Sciences. She has 16 years of applied experience in cancer research and the implementation of epidemiologic and statistical methods used to synthesize epidemiologic data in academic, government, and industry settings.
She is engaged in external collaborations including the Observational Health Data Sciences and Informatics (OHDSI). She holds an adjunct faculty position at the JHU School of Public Health.
Disclosure information not submitted.
Developing Code Lists for Pharmacoepidemiology: The How and Why?
Friday, August 25, 2023
10:30 AM – 12:00 PM ADT
Friday, August 25, 2023
2:15 PM – 2:30 PM ADT